Chemotherapy-associated VTE risk
Very high-risk site (stomach, pancreas)
High-risk site (lung, lymphoma, gynae, bladder, testis)
Platelets ≥ 350 ×10⁹/L
Hb < 100 g/L or using ESA
Leucocytes > 11 ×10⁹/L
BMI ≥ 35
Khorana Score
0
Low risk — no routine prophylaxis
Clinical Decisions in Seconds